Cardinal cutting 1,300 jobs ahead of CareFusion spin-off
Falling sales to hospitals are forcing Cardinal Health to cut 1,300 jobs from the clinical and medical products units that it plans to float under the CareFusion banner later this year.
Archives for April 1, 2009
PharmaNet now private as JLL deal goes through
Top 10 contract research organization (CRO) PharmaNet has gone into private hands following the conclusion of its acquisition by private equity firm JLL Partners.
Calls for IRB reform gain volume in US
Calls for a comprehensive reform of the system of Institutional Review Boards to protect patients in clinical trials have been voiced at a hearing of the House Subcommittee on Oversight and Investigations in the US.
Altea inks deal to use Byetta with PassPort patch
The search for more convenient diabetes treatments continues, with Altea Therapeutics reaching a $46m agreement with Eli Lilly and Amylin to develop a transdermal patch administering Byetta.
Sanofi leads pack in €5bn+ pursuit of Solvay; reports
Sanofi-Aventis had a €5bn ($6.6bn) bid for Solvay’s pharma business rejected, according to media reports, but several other companies are believed to be interested in the Belgian firm.
Patheon forms alliance with India’s Kemwell
Patheon and India’s Kemwell have formed an alliance under which they will refer and market each others' services to development and manufacturing clients
Catalent sells French solid dose plant to Bavaria
US contracting giant Catalent Pharma Solutions has sold its manufacturing unit in Osny, France to Germany’s Bavaria Industriekapital.
Pharming economical for HIV microbicide production; study
Researchers have used plants from the tobacco family as a large-scale, cost-effective method of producing a HIV inhibitor, which could lead to the creation of a female controlled intervention to stop viral transmission.
Oracle to add Relsys to healthcare portfolio
Enterprise software company Oracle is to acquire Relsys, a specialist in drug safety and pharmacovigilance applications, for an undisclosed figure.